(Q46031237)

English

Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157).

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157). (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

phase II clinical trial

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Frank L. Meyskens, Jr.

1

object named as

Meyskens FL Jr

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

author name string

Jacobson J

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Nguyen B

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Weiss GR

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Gandara DR

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

MacDonald JS

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

publication date

1 January 1998

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Investigational New Drugs

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

16

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

171-173

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

https://scigraph.springernature.com/pub.10.1023/a:1006032706362

0 references

Hepatoma/merbarone. A Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of retinoic acid α and β receptor genes in liver and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006032706362

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9848581

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46031237&oldid=2077315540"